BindingDB logo
myBDB logout

null

SMILES: FC(F)(F)c1ccc(NC(=O)N[C@@H]2CCCN(C2=O)c2ccc(nc2)N2CCOCC2)cc1

InChI Key: InChIKey=OSLYKVGNJHFYQN-GOSISDBHSA-N

Find this compound or compounds like it in BindingDB or PDB:
   Substructure
Similarity at least:  must be >=0.5
Exact match

Activity Spreadsheet -- Enzyme Inhibition Constant Data from BindingDB

Found 2 hits for monomerid = 497403   
Target/Host
(Institution)
LigandTarget/Host
Links
Ligand
Links
Trg + Lig
Links
Ki
nM
ΔG°
kcal/mole
IC50
nM
Kd
nM
EC50/IC50
nM
koff
s-1
kon
M-1s-1
pHTemp
°C
fMet-Leu-Phe receptor


(Homo sapiens (Human))
BDBM497403
PNG
(US11008301, Example 54)
Show SMILES FC(F)(F)c1ccc(NC(=O)N[C@@H]2CCCN(C2=O)c2ccc(nc2)N2CCOCC2)cc1 |r|
Show InChI InChI=1S/C22H24F3N5O3/c23-22(24,25)15-3-5-16(6-4-15)27-21(32)28-18-2-1-9-30(20(18)31)17-7-8-19(26-14-17)29-10-12-33-13-11-29/h3-8,14,18H,1-2,9-13H2,(H2,27,28,32)/t18-/m1/s1
PDB

Reactome pathway
KEGG

UniProtKB/SwissProt

DrugBank
antibodypedia
GoogleScholar
AffyNet 
PC cid
PC sid
UniChem
US Patent
n/an/an/an/a 920n/an/an/an/a



Bristol-Myers Squibb Company

US Patent


Assay Description
FPR2 and FPR1 Cyclic Adenosine Monophosphate (cAMP) Assays. A mixture of forskolin (5 μM final for FPR2 or 10 μM final for FPR1) and IBMX (...


US Patent US11008301 (2021)

More data for this
Ligand-Target Pair
N-formyl peptide receptor 2


(Homo sapiens (Human))
BDBM497403
PNG
(US11008301, Example 54)
Show SMILES FC(F)(F)c1ccc(NC(=O)N[C@@H]2CCCN(C2=O)c2ccc(nc2)N2CCOCC2)cc1 |r|
Show InChI InChI=1S/C22H24F3N5O3/c23-22(24,25)15-3-5-16(6-4-15)27-21(32)28-18-2-1-9-30(20(18)31)17-7-8-19(26-14-17)29-10-12-33-13-11-29/h3-8,14,18H,1-2,9-13H2,(H2,27,28,32)/t18-/m1/s1
PDB

NCI pathway
Reactome pathway
KEGG

UniProtKB/SwissProt

antibodypedia
GoogleScholar
AffyNet 
PC cid
PC sid
UniChem
US Patent
n/an/an/an/a 31n/an/an/an/a



Bristol-Myers Squibb Company

US Patent


Assay Description
FPR2 and FPR1 Cyclic Adenosine Monophosphate (cAMP) Assays. A mixture of forskolin (5 μM final for FPR2 or 10 μM final for FPR1) and IBMX (...


US Patent US11008301 (2021)

More data for this
Ligand-Target Pair